An assessment of hepatitis e virus (HEV) in US blood donors and recipients: No detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2505-2511

  Xu, Chenyu ^a,b,c   Wang, Richard Y ^a,b,c   Schechterly, Cathy A ^a,b,c   Ge, Shengxiang ^a,b,c   Shih, James W ^a,b,c   Xia, Ning Shao ^a,b,c   Luban, Naomi L C ^a,b,c   Alter, Harvey J ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b XIAMEN UNIVERSITY   (China)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; EPIDEMIOLOGY; GENETICS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PROSPECTIVE STUDY; REGISTER; SEROLOGY; STATISTICS; UNITED STATES; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MASS SCREENING; NATIONAL INSTITUTES OF HEALTH (U.S.); PROSPECTIVE STUDIES; REGISTRIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; UNITED STATES;

EID: 84891703675     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12326     Document Type: Article

References (26)

1. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecaloral route. Intervirology 1983;20:23-31.
2. Labrique AB, Thomas DL, Stoszek SK, Nelson KE. Hepatitis E: an emerging infectious disease. Epidemiol Rev 1999;21: 162-79.
3. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
4. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, Banks M, Ijaz S, Bendall RP. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:784-90.
5. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-12.
6. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010;48:317-8.
7. Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012; 103:89-90.
8. Barnaud E, Rogee S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol 2012;78: 5153-9.
9. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825-34.
10. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet 2012;379: 2477-88.
11. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG. Transfusion-transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006;16:79-83.
12. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, Kato T, Nishimori H, Tsuji K, Maguchi H, Yoshida J, Maekubo H, Mishiro S, Ikeda H. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic foodborne route. Transfusion 2008;48:1368-75.
13. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, Shimizu K, Moriyama M. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37:113-20.
14. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-7.
15. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009;150:430-1.
16. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009;200:48-56.
17. Holmberg SD. Hepatitis E in the United States. In: Hepatitis E in the United States. An NIH ResearchWorkshop; March 26, 2012; Bethesda, MD. p. 14-5. [cited 2013 Jun 24]. Available from: URL: http://www3.niddk.nih.gov/fund/other/ HepE2012/HepatitisE2012ProgramBook.pdf
18. Dalton H. Diagnostic Assays for HEV. In: Hepatitis E in the United States. An NIH ResearchWorkshop; March 26, 2012; Bethesda, MD. p. 5-6. [cited 2013 Jun 24]. Available from: URL: http://www3.niddk.nih.gov/fund/other/ HepE2012/HepatitisE2012ProgramBook.pdf
19. Zhang J, Ge SX, Huang GY, Li SW, He ZQ, Wang YB, Zheng YJ, Gu Y, Ng MH, Xia NS. Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 2003;71: 518-26.
20. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006;131:65-71.
21. Zhang J, Gu Y, Ge SX, Li SW, He ZQ, Huang GY, Zhuang H, Ng MH, Xia NS. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005;23:2881-92.
22. Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983;249:1743-5.
23. Lilienfeld D, Stolley P. Foundations of epidemiology. 3rd ed. New York: Oxford University Press; 1994.
24. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805.
25. Park HK, Jeong SH, Kim JW, Woo BH, Lee DH, Kim HY, Ahn S. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis 2012;12:142.
26. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.